Journal
ADVANCED HEALTHCARE MATERIALS
Volume 3, Issue 9, Pages 1430-1438Publisher
WILEY
DOI: 10.1002/adhm.201300515
Keywords
bioorthogonal chemistry; cell surface engineering; drug delivery; dendrimers; imaging
Funding
- National Science Foundation (CAREER) [CBET0954957]
- NIH-NINDS Center [5P30NS047463]
- Directorate For Engineering
- Div Of Chem, Bioeng, Env, & Transp Sys [0954957] Funding Source: National Science Foundation
Ask authors/readers for more resources
Immobilizing highly branched polyamidoamine (PAMAM) dendrimers to the cell surface represents an innovative method of enhancing cell surface loading capacity to deliver therapeutic and imaging agents. In this work, hybridized immune cells, that is, macrophage RAW264.7 (RAW), with PAMAM dendrimer G4.0 (DEN) on the basis of bioorthogonal chemistry are clicked. Efficient and selective cell surface immobilization of dendrimers is confirmed by confocal microscopy. Viability and motility of RAW-DEN hybrids remain the same as untreated RAW cells according to WST-1 assay and wound closure assay. Furthermore, Western blot analysis reveals that there are no significant alterations in the expression levels of signaling molecules AKT, p38, and NFB (p65) and their corresponding activated (phosphorylated) forms in RAW cells treated with azido sugar and dendrimer, indicating that the hybridization process neither induced cell stress response nor altered normal signaling pathways. Taken together, this work shows the feasibility of applying bioorthogonal chemistry to create cell-nanoparticle hybrids and demonstrates the noninvasiveness of this cell surface engineering approach.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available